Few retears after partial-, full-thickness rotator cuff repair

Few retears after partial-, full-thickness rotator cuff repair
Retear rates after arthroscopic repair of both partial-thickness and full-thickness rotator cuff tears are low, with no difference in the retear rate or postoperative shoulder stiffness rate for tear thickness, according to a study published in the June 20 issue of The Journal of Bone & Joint Surgery.

(HealthDay) -- Retear rates after arthroscopic repair of both partial-thickness and full-thickness rotator cuff tears are low, with no difference in the retear rate or postoperative shoulder stiffness rate for tear thickness, according to a study published in the June 20 issue of The Journal of Bone & Joint Surgery.

Karin S. Peters, M.D., from Kliniek Klein Rosendael in the Netherlands, and colleagues compared outcomes for 105 consecutive patients who had a full-thickness rotator cuff tear measuring <3 cm² with 64 patients who had a partial-thickness tear. A knotless single-row arthroscopic repair was used to fix all tears. Patients were assessed using the American Shoulder and Elbow Surgeons (ASES) score preoperatively and at six, 12, and 24 weeks and two years after surgery.

The researchers found that, in both groups, examiner-determined postoperative stiffness was common at six weeks (50 percent in the partial-thickness versus 47 percent in full-thickness groups). Compared with preoperative findings, stiffness decreased from preoperative findings to 21 and 19 percent, respectively, at three months and to 15 and 14 percent, respectively, at six months. At six months the ultrasound-determined retear rate was low (5 and 10 percent in the partial-thickness and full-thickness groups, respectively), but increased at 24 months to 10 and 20 percent, respectively. At both six months and 24 months the ASES score and all pain scores were significantly improved from preoperative scores in both groups.

"Arthroscopic repair of partial-thickness and small- and medium-sized full-thickness rotator cuff tears was associated with excellent medium-term clinical outcomes with low retear rates," the authors write.

One of the institutions received funding from the ArthroCare Corporation.

Abstract

Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Hormonal therapy for transsexualism safe and effective

14 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

18 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...